The Clearity Foundation’s Personalized Medicine in Oncology Series offers an interactive discussion of whether physicians and payers, who bridge the gap between technology developers and patients, are likely to be allies or antagonists in making personalized medicine a reality for cancer patients. The panel will look at the commercial challenges of personalized medicine from both of these perspectives and will provide insights as to where opportunities exist for significant advances in patient outcomes. Please RSVP by sending an email to [email protected]